Last reviewed · How we verify

NCT06184282

Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer

Completed NA Last updated 3 January 2024
What this trial tests

NA trial testing MEBO in Mebo in 28 participants. Completed in 1 August 2023.

Timeline
1 July 2023
Primary endpoint
1 August 2023
1 August 2023

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 July 2023
Primary completion1 August 2023
Estimated completion1 August 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 20 to 50, any sex, with Mebo or Lidocaine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess topical MEBO application on pain relief and wound healing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06184282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing